Literature DB >> 1617725

CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130.

N Y Ip1, S H Nye, T G Boulton, S Davis, T Taga, Y Li, S J Birren, K Yasukawa, T Kishimoto, D J Anderson.   

Abstract

Ciliary neurotrophic factor (CNTF) has a variety of actions within the nervous system. While some of the actions of leukemia inhibitory factor (LIF) on neurons resemble those of CNTF, LIF also has broad actions outside of the nervous system that in many cases mimic those of interleukin-6 (IL-6). Comparison of the tyrosine phosphorylations and gene activations induced by CNTF and LIF in neuron cell lines reveals that they are indistinguishable and also very similar to signaling events that characterize LIF and IL-6 responses in hematopoietic cells. We provide a basis for the overlapping actions of these three factors by demonstrating that the shared CNTF and LIF signaling pathways involve the IL-6 signal transducing receptor component gp130. Thus, the receptor system for CNTF is surprisingly unlike those used by the nerve growth factor family of neurotrophic factors, but is instead related to those used by a subclass of hematopoietic cytokines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1617725     DOI: 10.1016/0092-8674(92)90634-o

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  131 in total

Review 1.  Signaling through sphingolipid microdomains of the plasma membrane: the concept of signaling platform.

Authors:  D C Hoessli; S Ilangumaran; A Soltermann; P J Robinson; B Borisch
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 2.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

3.  Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.

Authors:  Y Ito; M Yamamoto; N Mitsuma; M Li; N Hattori; G Sobue
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

4.  Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution.

Authors:  J G Zhang; C M Owczarek; L D Ward; G J Howlett; L J Fabri; B A Roberts; N A Nicola
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

5.  Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.

Authors:  T Taga; M Narazaki; K Yasukawa; T Saito; D Miki; M Hamaguchi; S Davis; M Shoyab; G D Yancopoulos; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 6.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  Ciliary neurotrophic factor improves muscle fibre reinnervation after facial nerve crush in young rats.

Authors:  H J Ulenkate; E C Kaal; W H Gispen; F G Jennekens
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  CD133+ adult human retinal cells remain undifferentiated in Leukaemia Inhibitory Factor (LIF).

Authors:  Debra A Carter; Andrew D Dick; Eric J Mayer
Journal:  BMC Ophthalmol       Date:  2009-02-23       Impact factor: 2.209

9.  Ciliary neurotrophic factor receptor regulation of adult forebrain neurogenesis.

Authors:  Nancy Lee; Myra K Batt; Brigitte A Cronier; Michele C Jackson; Jennifer L Bruno Garza; Dennis S Trinh; Carter O Mason; Rachel P Spearry; Shayon Bhattacharya; Rachel Robitz; Masato Nakafuku; A John MacLennan
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

Review 10.  Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.

Authors:  Suzan Dziennis; Nabil J Alkayed
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.